Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

» BMTI's 10-Y Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with BMTI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies

BioMimetic Therapeutics, Inc. develops and commercializes innovative products to help stimulate the body's natural tissue regenerative process. The company's protein therapeutic-device combination products have the potential to improve the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments and cartilage. Its platform regenerative technology, which incorporates a potent version of one of the body's natural key stimulators of tissue repair, might offer physicians advanced biological solutions to actively stimulate tissue healing and regeneration. This technology is safe and effective in stimulating bone and periodontal regeneration in the jaws with the U.S. and Canadian regulatory approvals of its first product, GEM 21S Growth-factor Enhanced Matrix. With the divestiture of GEM 21S in January 2008, the company is now focused on developing this technology to stimulate tissue healing in orthopedic applications such as distal radius, or wrist, fractures and fusions of the bones in the foot and ankle to eliminate chronic pain from trauma or arthritis, and potentially spine and sports injury applications. The company's current product candidates use the same key stimulator as GEM 21S, and are designed to target a range of clinical indications in bone, cartilage, ligament and tendon repair. The company currently has seven orthopedic clinical studies that are completed or are under way which seek to demonstrate the safety, clinical utility and/or efficacy of its product candidates in the pipeline, including its orthopedic product candidate Augment Bone Graft (Augment), formerly GEM OS1 bone graft, in treating bone defects and injuries. In addition, it has pre-clinical programs focused on the development of treatments for bone defects in the spine and various sports injury applications, including those requiring cartilage, ligament and tendon repair. Augment and OsteoMimetic are the company's trademarks. The company has developed a network of suppliers, manufacturers, and contract service providers to provide sufficient quantity of its product candidates through the development and clinical testing phases.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)